Sabby Management, LLC Mannkind Corp Transaction History

Sabby Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$1.14 - $2.25 $14,588 - $28,793	-12,797 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.02 - $2.05 $13,052 - $26,233	12,797 New	12,797 $14,000
Q2 2018 Aug 14, 2018	SELL	$1.59 - $2.38 $321,033 - $480,541	-201,908 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$2.28 - $3.8 $2.84 Million - $4.73 Million	-1,244,992 Reduced 86.05%	201,908 $460,000
Q4 2017 Feb 14, 2018	BUY	$2.28 - $6.71 $3.3 Million - $9.71 Million	1,446,900	1,446,900 $3.36 Million

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.78B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.